PMID- 24665163 OWN - NLM STAT- MEDLINE DCOM- 20141215 LR - 20211021 IS - 1466-1861 (Electronic) IS - 0962-9351 (Print) IS - 0962-9351 (Linking) VI - 2014 DP - 2014 TI - Effect of the administration of alpha-lipoic acid on contrast sensitivity in patients with type 1 and type 2 diabetes. PG - 131538 LID - 10.1155/2014/131538 [doi] LID - 131538 AB - The aim of this study was to estimate the effects of oral supplementation of alpha-lipoic acid (ALA) on contrast sensitivity (CS) in patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). The study included 12 patients with T1DM aged 43+/-12 years, 48 patients with T2DM aged 59+/-10 years, and 20 control subjects aged 33+/-8 years. Patients from each studied group, including the control group, were randomly assigned to receive 300 mg of ALA orally once daily for 3 months. CS was evaluated with the Functional Acuity Contrast Test (FACT, Stereo Optical). In the group of patients with T1DM receiving ALA for 3 months CS remained stable and improved in those with T2DM. Reduction of CS in both T1DM and T2DM patients without alpha-lipoic acid supplementation was observed. In the control group on alpha-lipoic acid supplementation, CS improvement was noticed at one spatial frequency. Changes in the CS were observed, despite stable visual acuity and eye fundus image in all studied subjects. Our study demonstrated that oral administration of alpha-lipoic acid had influence on CS in both T1DM and T2DM patients. FAU - Gebka, Anna AU - Gebka A AD - Department of Ophthalmology, Medical University of Gdansk, Smoluchowskiego 17, 80-214 Gdansk, Poland. FAU - Serkies-Minuth, Ewelina AU - Serkies-Minuth E AUID- ORCID: 0000-0002-5928-7056 AD - Department of Ophthalmology, Medical University of Gdansk, Smoluchowskiego 17, 80-214 Gdansk, Poland. FAU - Raczynska, Dorota AU - Raczynska D AD - Department of Ophthalmology, Medical University of Gdansk, Smoluchowskiego 17, 80-214 Gdansk, Poland ; Department of Anesthesiology and Intensive Care Medicine, Medical University of Gdansk, Smoluchowskiego 17, 80-214 Gdansk, Poland. LA - eng PT - Journal Article PT - Randomized Controlled Trial DEP - 20140210 PL - United States TA - Mediators Inflamm JT - Mediators of inflammation JID - 9209001 RN - 0 (Antioxidants) RN - 73Y7P0K73Y (Thioctic Acid) SB - IM MH - Adult MH - Aged MH - Antioxidants/administration & dosage MH - Case-Control Studies MH - Contrast Sensitivity/*drug effects MH - Diabetes Mellitus, Type 1/*physiopathology MH - Diabetes Mellitus, Type 2/*physiopathology MH - Diagnostic Techniques, Ophthalmological MH - Dietary Supplements MH - Female MH - Fundus Oculi MH - Humans MH - Male MH - Middle Aged MH - Thioctic Acid/*administration & dosage MH - Visual Acuity PMC - PMC3934387 EDAT- 2014/03/26 06:00 MHDA- 2014/12/17 06:00 PMCR- 2014/02/10 CRDT- 2014/03/26 06:00 PHST- 2013/08/16 00:00 [received] PHST- 2013/11/28 00:00 [revised] PHST- 2013/12/24 00:00 [accepted] PHST- 2014/03/26 06:00 [entrez] PHST- 2014/03/26 06:00 [pubmed] PHST- 2014/12/17 06:00 [medline] PHST- 2014/02/10 00:00 [pmc-release] AID - 10.1155/2014/131538 [doi] PST - ppublish SO - Mediators Inflamm. 2014;2014:131538. doi: 10.1155/2014/131538. Epub 2014 Feb 10.